Trial · NCT00319982
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Increase, Stability of, or Decrease in the Decline of Diastolic Function as Reflected by the Global Early Myocardial Relaxation (E') Velocity | I- Diltiazem | -0.06 | Standard Error 0.27 | cm/sec (difference final-baseline) | |
| Increase, Stability of, or Decrease in the Decline of Diastolic Function as Reflected by the Global Early Myocardial Relaxation (E') Velocity | II- Placebo | -0.21 | Standard Error 0.42 | cm/sec (difference final-baseline) | |
| Safety and Tolerability of Diltiazem Treatment | I- Diltiazem | 10 | Participants Reporting Adverse Events | ||
| Safety and Tolerability of Diltiazem Treatment | II- Placebo | 12 | Participants Reporting Adverse Events | ||
| Impact of Diltiazem on Heart Rate | I- Diltiazem | -4.9 | Standard Error 2.2 | beats/minute | |
| Impact of Diltiazem on Heart Rate | II- Placebo | 2.0 | Standard Error 2.6 | beats/minute | |
| Left Ventricular Cavity Size | I- Diltiazem | 0.60 | Standard Error 0.17 | z-score units | |
| Left Ventricular Cavity Size | II- Placebo | -0.53 | Standard Error 0.16 | z-score units | |
| Development of Left Ventricular Hypertrophy | I- Diltiazem | 2 | participants | ||
| Development of Left Ventricular Hypertrophy | II- Placebo | 2 | participants | ||
| Adherence to Study Medication | I- Diltiazem | 83 | Standard Deviation 10.8 | percentage of pills taken | |
| Adherence to Study Medication | II- Placebo | 90 | Standard Deviation 6.6 | percentage of pills taken | |
| Impact of Diltiazem on Systolic Blood Pressure | I- Diltiazem | -1.4 | Standard Error 1.7 | mmHg | |
| Impact of Diltiazem on Systolic Blood Pressure | II- Placebo | 2.1 | Standard Error 1.8 | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00319982/results